In HER2‐positive gastric cancer, Sui et al44 has demonstrated that increased miR‐125b level in tumor tissue was significantly associated with trastuzumab resistance, advanced malignant progression, as well as poor prognosis. This evidence concerns the gene ERBB2 and neoplasm.